Press Releases

Press Releases

Breaking news from across the pharma sector

Re:course AI Secures $4.3m to Reimagine Healthcare Training with AI-Powered Digital HumansRe:course AI Secures $4.3m to Reimagine Healthcare Training with AI-Powered Digital Humans
Re:course AI Secures $4.3m to Reimagine Healthcare Training with AI-Powered Digital Humans

Manchester, February 2nd, 2023 – Re:course AI, the artificial intelligence (AI) flight simulator for healthcare training, has secured $4.3 million in seed funding in a round led by Par Equity and including Northern Gritstone, the GMC Life Sciences Fund By Praetura, Rob Wood (founder of STEM Healthcare) and the founders of Current Health.

Feb 3, 2023 Press Releases
Eyenovia Showcases Microdose Array Print (MAP™) Technology at CES 2023 in Las VegasEyenovia Showcases Microdose Array Print (MAP™) Technology at CES 2023 in Las Vegas
Eyenovia Showcases Microdose Array Print (MAP™) Technology at CES 2023 in Las Vegas

LAS VEGAS, Jan. 31, 2023 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a pre-commercial ophthalmic technology company developing the Optejet® delivery system for use both in connection with its own drug-device therapeutic programs for mydriasis, presbyopia and pediatric progressive myopia as well as out-licensing for additional indications, showcased the Microdose Array Print (MAP™) Technology at CES 2023 in Las Vegas, Nevada, from Jan. 5-8.

Feb 1, 2023 Press Releases
Flexible containment specialist ONFAB appoints new business lead to drive European growthFlexible containment specialist ONFAB appoints new business lead to drive European growth
Flexible containment specialist ONFAB appoints new business lead to drive European growth

Flexible containment specialist ONFAB, part of the Envair Technology group, has appointed Francis Dechoux as its new European Business Lead.

Feb 1, 2023 Press Releases
X-Chem and Kymera Expand Existing PartnershipX-Chem and Kymera Expand Existing Partnership
X-Chem and Kymera Expand Existing Partnership

WALTHAM, Mass.; Jan. 31, 2023 (Business Wire) – X-Chem, the leading provider of innovative solutions in early-stage drug discovery, today announced the expansion of its collaboration with Kymera Therapeutics, Inc. (NASDAQ: KYMR).

Jan 31, 2023 Press Releases
Samsung Biologics Reports Fourth Quarter & Fiscal Year 2022 Financial ResultsSamsung Biologics Reports Fourth Quarter & Fiscal Year 2022 Financial Results
Samsung Biologics Reports Fourth Quarter & Fiscal Year 2022 Financial Results

Incheon, S. Korea, January 27, 2023 – Samsung Biologics (KRX: 207940.KS), the world’s leading contract development and manufacturing organization, today announced strong financial results for the fourth quarter and record-high earnings for the fiscal year 2022.

Jan 30, 2023 Press Releases
Mettler-Toledo showcase smart solutions at Interpack, boosting pharma & biopharma manufacturingMettler-Toledo showcase smart solutions at Interpack, boosting pharma & biopharma manufacturing
Mettler-Toledo showcase smart solutions at Interpack, boosting pharma & biopharma manufacturing

Giesen, Germany 30th January 2023 – Mettler-Toledo Product Inspection will bring a message of productivity and integration to the Interpack trade fair in May 2023. The company will be showing a wide range of smart product inspection solutions that can help pharmaceutical and biotechnology manufacturers manage the increasing need for digitalization in the marketplace, as well as helping combat rising manufacturing costs.

Jan 30, 2023 Press Releases
bit.bio chooses Automata for automating an aspect of its production of iPSC derived human cells bit.bio chooses Automata for automating an aspect of its production of iPSC derived human cells
bit.bio chooses Automata for automating an aspect of its production of iPSC derived human cells

26th January 2023, London UK – Automata, a leading robotics and automation company powering life sciences labs, today announced it is partnering with bit.bio, to automate a key aspect of the manufacturing process of their iPSC (induced pluripotent stem cell)-derived human cell products.

Jan 26, 2023 Press Releases
Evotec Announces Agreement with Janssen to Develop Immune-Based TherapiesEvotec Announces Agreement with Janssen to Develop Immune-Based Therapies
Evotec Announces Agreement with Janssen to Develop Immune-Based Therapies

HAMBURG, GERMANY / ACCESSWIRE / January 26, 2023 / Evotec SE (Frankfurt Stock Exchange:EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ:EVO) announced today that the Company has entered into a strategic collaboration and licence agreement with Janssen Biotech, Inc. ("Janssen"), one of the Janssen Pharmaceutical Companies of Johnson & Johnson.

Jan 26, 2023 Press Releases
Catalent Completes Commercial-Scale Plasmid DNA Manufacturing Facility in Gosselies, BelgiumCatalent Completes Commercial-Scale Plasmid DNA Manufacturing Facility in Gosselies, Belgium
Catalent Completes Commercial-Scale Plasmid DNA Manufacturing Facility in Gosselies, Belgium

SOMERSET, N.J. – January 26, 2023 – Catalent, the leader in enabling the development and supply of better treatments for patients worldwide, today announced the opening of a new commercial-scale plasmid DNA (pDNA) manufacturing facility at its European center of excellence for cell therapies, in Gosselies, Belgium.

Jan 26, 2023 Press Releases
Thermo Fisher and AstraZeneca partner to Develop Solid Tissue, Blood-Based Companion Diagnostic TestThermo Fisher and AstraZeneca partner to Develop Solid Tissue, Blood-Based Companion Diagnostic Test
Thermo Fisher and AstraZeneca partner to Develop Solid Tissue, Blood-Based Companion Diagnostic Test

24 January -- CARLSBAD, Calif.--(BUSINESS WIRE)-- As part of a global, multiyear agreement, Thermo Fisher Scientific today announced it is working with AstraZeneca to develop a solid tissue and blood-based companion diagnostic (CDx) test for Tagrisso (osimertinib).

Jan 25, 2023 Press Releases
Thermo Fisher Scientific Launches CE-IVD Marked Assay to Detect Treatment-Resistant Strains of HIV-1Thermo Fisher Scientific Launches CE-IVD Marked Assay to Detect Treatment-Resistant Strains of HIV-1
Thermo Fisher Scientific Launches CE-IVD Marked Assay to Detect Treatment-Resistant Strains of HIV-1

CARLSBAD, Calif.--(BUSINESS WIRE)-- Thermo Fisher Scientific, the world leader in serving science, today announced the launch of its CE-IVD marked Applied Biosystems TaqPath Seq HIV-1 Genotyping Kit, a Sanger sequencing-based assay that examines positive samples of human immunodeficiency virus (HIV) to identify genetic variants that may resist common antiretroviral therapeutics.

Jan 25, 2023 Press Releases
rms Company Scales Medical Device Production with Addition of 3D Systems’ DMP Flex 350 Dual rms Company Scales Medical Device Production with Addition of 3D Systems’ DMP Flex 350 Dual
rms Company Scales Medical Device Production with Addition of 3D Systems’ DMP Flex 350 Dual

ROCK HILL, South Carolina, January 19, 2023 – Today, 3D Systems (NYSE:DDD) announced rms Company, one of the largest contract manufacturers of high-quality, tight-tolerance medical devices in the world, has added the DMP Flex 350 Dual to its production workflow. rms has more than 30 3D Systems’ DMP 3D printers in its additive manufacturing facility enabling the company to provide a complete Powder to Package capability to medical device OEMs.

Jan 24, 2023 Press Releases